IL129237A0 - Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms - Google Patents

Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

Info

Publication number: IL129237A0
Authority: IL; Israel
Prior art keywords: colonisation; mupirocin; nasopharynx; medicament; manufacture
Prior art date: 1996-10-01

Application number

IL12923797A

Other languages

English (en)

Original Assignee

Smithkline Beecham Corp

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-01

Filing date

1997-09-29

Publication date

2000-02-17

1997-08-09 Priority claimed from GBGB9716805.8A external-priority patent/GB9716805D0/en

1997-09-11 Priority claimed from GBGB9719203.3A external-priority patent/GB9719203D0/en

1997-09-29 Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp

2000-02-17 Publication of IL129237A0 publication Critical patent/IL129237A0/xx

Links

MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 title 1
208000035143 Bacterial infection Diseases 0.000 title 1
208000022362 bacterial infectious disease Diseases 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
229960003128 mupirocin Drugs 0.000 title 1
229930187697 mupirocin Natural products 0.000 title 1
DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 title 1
210000001989 nasopharynx Anatomy 0.000 title 1
244000052769 pathogen Species 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL12923797A 1996-10-01 1997-09-29 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms IL129237A0 (en)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US2722296P	1996-10-01	1996-10-01
US2722396P	1996-10-01	1996-10-01
US2722496P	1996-10-01	1996-10-01
GBGB9716805.8A GB9716805D0 (en)	1997-08-09	1997-08-09	Novel composition and use
GBGB9719203.3A GB9719203D0 (en)	1997-09-11	1997-09-11	Novel composition and use
PCT/GB1997/002664 WO1998014189A1 (en)	1996-10-01	1997-09-29	Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

Publications (1)

Publication Number	Publication Date
IL129237A0 true IL129237A0 (en)	2000-02-17

Family

ID=27517419

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12923797A IL129237A0 (en)	1996-10-01	1997-09-29	Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

Country Status (17)

Country	Link
US (1)	US6001870A (pt)
EP (1)	EP0939631A1 (pt)
JP (1)	JP2001504091A (pt)
KR (1)	KR20000048812A (pt)
CN (1)	CN1239427A (pt)
AR (1)	AR010995A1 (pt)
AU (1)	AU724070B2 (pt)
BR (1)	BR9711843A (pt)
CA (1)	CA2267248A1 (pt)
CZ (1)	CZ112499A3 (pt)
HU (1)	HUP9904308A3 (pt)
IL (1)	IL129237A0 (pt)
NO (1)	NO991548L (pt)
NZ (1)	NZ334913A (pt)
PL (1)	PL332642A1 (pt)
TR (1)	TR199900733T2 (pt)
WO (1)	WO1998014189A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0939631A1 (en) *	1996-10-01	1999-09-08	Smithkline Beecham Corporation	Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
CO4910145A1 (es)	1996-10-01	2000-04-24	Smithkline Beecham Corp	Uso
CA2299298A1 (en) *	1997-08-09	1999-02-18	Jane Elizabeth Hilton	Compositions for nasal administration
UY25225A1 (es)	1997-10-29	2000-12-29	Smithkline Beecham Plc	Derivados de pleuromutilina utiles como agentes antimicrobianos
GB9808470D0 (en)	1998-04-22	1998-06-17	Smithkline Beecham Plc	Novel process and apparatus
GB9902138D0 (en)	1999-02-02	1999-03-24	Smithkline Beecham	Container
TR200102234T2 (tr) *	1999-02-03	2002-10-21	Biogal Gyogyszergyar Rt.	Psödomonik asit A antibiyotiğinin mikrobiyolojik yöntem ile hazırlanması için işlem
AU5397300A (en) *	1999-06-02	2000-12-28	Hexal Ag	Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water
US6156294A (en) *	1999-11-28	2000-12-05	Scientific Development And Research, Inc.	Composition and method for treatment of otitis media
US6676930B2 (en) *	1999-11-28	2004-01-13	Scientific Development And Research, Inc.	Composition and method for treatment of otitis media
CA2448547A1 (en) *	2001-06-21	2003-01-03	Biogal Gyogyszergyar Rt.	Metabolic controlled fermentation process for pseudomonic acid production
KR20040075857A (ko) *	2001-12-28	2004-08-30	비오갈 기오기스제르갸르 알티.	결정질 및 비결정질 무피로신 칼슘의 제조 방법
US20050058673A1 (en) *	2003-09-09	2005-03-17	3M Innovative Properties Company	Antimicrobial compositions and methods
WO2005117837A1 (en) *	2004-06-01	2005-12-15	Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg	Process for preparation of amorphous form of a drug
CN101137359B (zh) *	2005-03-10	2011-01-12	3M创新有限公司	治疗耳感染的方法
US10918618B2 (en)	2005-03-10	2021-02-16	3M Innovative Properties Company	Methods of reducing microbial contamination
AU2006223136A1 (en)	2005-03-10	2006-09-21	3M Innovative Properties Company	Antimicrobial compositions comprising esters of hydroxycarboxylic acids
GB2437488A (en) *	2006-04-25	2007-10-31	Optinose As	Pharmaceutical oily formulation for nasal or buccal administration
US7993675B2 (en)	2006-05-10	2011-08-09	Medtronic Xomed, Inc.	Solvating system and sealant for medical use in the sinuses and nasal passages
US20070264296A1 (en) *	2006-05-10	2007-11-15	Myntti Matthew F	Biofilm extracellular polysachharide solvating system
US7959943B2 (en)	2006-05-10	2011-06-14	Medtronics Xomed, Inc.	Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en)	2006-05-10	2011-07-12	Medtronic Xomed, Inc.	Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US8088095B2 (en)	2007-02-08	2012-01-03	Medtronic Xomed, Inc.	Polymeric sealant for medical use
JP2011524367A (ja)	2008-06-12	2011-09-01	メドトロニック・ゾーメド・インコーポレーテッド	慢性の創傷を治療するための方法
US20100021563A1 (en) *	2008-07-24	2010-01-28	Paul Levesque	Compositions comprising coconut oil and methods of use thereof
US20100086576A1 (en)	2008-10-06	2010-04-08	Myntti Matthew F	Antimicrobial composition and methods of making and using same
JP6463629B2 (ja)	2011-05-10	2019-02-06	ネクストサイエンスアイピーホールディングスピーティワイエルティーディ	抗菌性固体およびその製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ200918A (en) *	1981-07-02	1985-07-31	Gist Brocades Nv	Stable fatty oil-in-water emulsion cream for topical application
CA1196284A (en) *	1982-05-28	1985-11-05	Joshua Oduro-Yeboah	Pharmaceutical formulations
SE8206744D0 (sv) *	1982-11-26	1982-11-26	Fluidcarbon International Ab	Preparat for kontrollerad avgivning av substanser
GB8415579D0 (en) *	1984-06-19	1984-07-25	Beecham Group Plc	Compounds
GB8530796D0 (en) *	1985-12-13	1986-01-22	Beecham Group Plc	Pharmaceutical composition
IE59628B1 (en) *	1986-06-26	1994-03-09	Beecham Group Plc	Treatment of fungal infections
US5594026A (en) *	1990-12-11	1997-01-14	Smithkline Beecham Group P.L.C.	Polymorphs of crystalline mupirocin
JPH09506865A (ja) *	1993-10-22	1997-07-08	スミスクライン・ビーチャム・コーポレイション	新規組成物
EP0939631A1 (en) *	1996-10-01	1999-09-08	Smithkline Beecham Corporation	Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

1997
- 1997-09-29 EP EP97943966A patent/EP0939631A1/en not_active Withdrawn
- 1997-09-29 NZ NZ334913A patent/NZ334913A/en unknown
- 1997-09-29 PL PL97332642A patent/PL332642A1/xx unknown
- 1997-09-29 TR TR1999/00733T patent/TR199900733T2/xx unknown
- 1997-09-29 BR BR9711843-5A patent/BR9711843A/pt not_active IP Right Cessation
- 1997-09-29 HU HU9904308A patent/HUP9904308A3/hu unknown
- 1997-09-29 CA CA002267248A patent/CA2267248A1/en not_active Abandoned
- 1997-09-29 CZ CZ991124A patent/CZ112499A3/cs unknown
- 1997-09-29 CN CN97180242A patent/CN1239427A/zh active Pending
- 1997-09-29 KR KR1019990702807A patent/KR20000048812A/ko not_active Withdrawn
- 1997-09-29 WO PCT/GB1997/002664 patent/WO1998014189A1/en not_active Ceased
- 1997-09-29 AU AU45623/97A patent/AU724070B2/en not_active Ceased
- 1997-09-29 IL IL12923797A patent/IL129237A0/xx unknown
- 1997-09-29 JP JP51631398A patent/JP2001504091A/ja active Pending
- 1997-09-30 US US08/940,730 patent/US6001870A/en not_active Expired - Fee Related
- 1997-09-30 AR ARP970104497A patent/AR010995A1/es unknown
1999
- 1999-03-30 NO NO991548A patent/NO991548L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
PL332642A1 (en)	1999-09-27
KR20000048812A (ko)	2000-07-25
AU4562397A (en)	1998-04-24
EP0939631A1 (en)	1999-09-08
HUP9904308A2 (hu)	2001-04-28
NZ334913A (en)	2001-03-30
NO991548D0 (no)	1999-03-30
WO1998014189A1 (en)	1998-04-09
NO991548L (no)	1999-03-31
US6001870A (en)	1999-12-14
TR199900733T2 (xx)	1999-07-21
BR9711843A (pt)	2001-07-31
AU724070B2 (en)	2000-09-14
HUP9904308A3 (en)	2002-06-28
JP2001504091A (ja)	2001-03-27
CZ112499A3 (cs)	1999-08-11
AR010995A1 (es)	2000-08-02
CA2267248A1 (en)	1998-04-09
CN1239427A (zh)	1999-12-22

Publication	Publication Date	Title
IL129237A0 (en)	2000-02-17	Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
NZ506058A (en)	2003-04-29	Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
WO2001045679A3 (de)	2002-07-18	Verwendung von chemotherapeutika zur topischen behandlung
GB0125222D0 (en)	2001-12-12	Composition for the treatment of microbial infections
PT102450A (pt)	2001-02-01	Formulacao farmaceutica de libertacao modificada compreendendo amoxicilina e clavulanato de potassio e utilizacao destes compostos no fabrico de um medicamento para o tratamento de infeccoes bacterianas
GR3036015T3 (en)	2001-09-28	Substituted oxazolidinone and their use as antibacterial medicine
EP0326891A3 (en)	1990-04-25	Antibacterial agents
IL239913B (en)	2019-01-31	The use of delvavancin in a pharmaceutical carrier is accepted in the production of a drug for the treatment of bacterial infections
IL146255A0 (en)	2002-07-25	Attenuated microorganisms for the treatment of infection
WO1997018790A3 (en)	1997-07-31	Therapeutic and diagnostic agents for the treatment of microbial infections
AU2000255628A1 (en)	2001-10-08	Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
AU9114998A (en)	2000-03-14	Method of enhancing the antimicrobial properties of antibacterial antibiotics
CA2267309A1 (en)	1998-04-02	Use of 1-hydroxy-2-pyridones for the treatment of skin infections
FR2782093B1 (fr)	2002-02-08	Procede de preparation de cultures de bacteries lactiques
CA2380455A1 (en)	2001-03-01	9a-azalides with antibacterial activity
PT1227827E (pt)	2005-07-29	Bacterias acido-lacticas para o tratamento e/ou profilaxia da giardiase
NZ509051A (en)	2003-01-31	Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
MY104109A (en)	1993-12-31	Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
HK1022629A (en)	2000-08-18	Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
EP2250887A3 (en)	2010-11-24	Use of non-antibacterial tetracycline analog CMT-1002 and formulations thereof for the treatment of bacterial exotoxins
CA2114629A1 (en)	1993-02-18	Receptor conjugates for targeting antibiotics to bacteria
CA2468036A1 (en)	2003-06-05	A method of treating bacterial infections using gemifloxacin or a salt thereof and a .beta.-lactam antibiotic
AU3333695A (en)	1995-12-21	Methods and products for the control of pathogenic bacteria
AU1968399A (en)	1999-07-12	Pharmaceutical compositios containing (s)-cefuroxime axetil and their use for the treatment of bacterial infections
BG98085A (en)	1995-04-28	Method for the treatment of bacterial infections